Sustaining Vaccine Confidence in the 21st Century

Vaccines
Karin HardtFrançois P Meurice

Abstract

Vaccination provides many health and economic benefits to individuals and society, and public support for immunization programs is generally high. However, the benefits of vaccines are often not fully valued when public discussions on vaccine safety, quality or efficacy arise, and the spread of misinformation via the internet and other media has the potential to undermine immunization programs. Factors associated with improved public confidence in vaccines include evidence-based decision-making procedures and recommendations, controlled processes for licensing and monitoring vaccine safety and effectiveness and disease surveillance. Community engagement with appropriate communication approaches for each audience is a key factor in building trust in vaccines. Vaccine safety/quality issues should be handled rapidly and transparently by informing and involving those most affected and those concerned with public health in effective ways. Openness and transparency in the exchange of information between industry and other stakeholders is also important. To maximize the safety of vaccines, and thus sustain trust in vaccines, partnerships are needed between public health sector stakeholders. Vaccine confidence can be improved through c...Continue Reading

References

May 1, 1994·Vaccine·R T ChenS G Wassilak
Nov 30, 1999·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
May 7, 2003·Risk Analysis : an Official Publication of the Society for Risk Analysis·Yasunobu Maeda, Makota Miyahara
May 31, 2003·BMJ : British Medical Journal·Kamran Abbasi, Richard Smith
May 31, 2003·BMJ : British Medical Journal·Joel LexchinOtavio Clark
May 31, 2003·BMJ : British Medical Journal·Richard Smith
May 31, 2003·BMJ : British Medical Journal·Andrew Herxheimer
Sep 10, 2004·JAMA : the Journal of the American Medical Association·Catherine D DeAngelisUNKNOWN International Committee of Medical Journal Editors
Nov 26, 2005·BMJ : British Medical Journal·Rebecca Coombes
Dec 15, 2005·BMJ : British Medical Journal·Cate WallaceLyndal J Trevena
Dec 24, 2005·Expert Review of Vaccines·Jose A LebronBrian J Ledwith
Nov 15, 2006·Human Vaccines·Karen NoakesDavid Salisbury
Mar 29, 2007·PLoS Medicine·Ayodele Samuel Jegede
Oct 25, 2007·Medical Care·Tracy A LieuUNKNOWN Vaccine Safety Datalink Rapid Cycle Analysis Team
Nov 15, 2007·JAMA : the Journal of the American Medical Association·Sandra W RoushUNKNOWN Vaccine-Preventable Disease Table Working Group
Jun 21, 2008·BMJ : British Medical Journal·Ray Moynihan
Aug 16, 2008·BMJ : British Medical Journal·Ray Moynihan
Feb 7, 2009·Expert Review of Vaccines·Chuen-Yen LauZuhayr Kafaar
Jun 16, 2009·Biologicals : Journal of the International Association of Biological Standardization· Who
Oct 16, 2009·BMC International Health and Human Rights·Philippe DuclosThomas Cherian
Dec 17, 2009·Vaccine·Kate TaylorJean Stéphenne
Mar 17, 2010·Current Problems in Pediatric and Adolescent Health Care·John D LantosBeverly L Connelly
May 28, 2010·Journal of the Royal Society, Interface·Sebastian FunkVincent A A Jansen
Jan 8, 2011·BMC Public Health·Lynn B Myers, Robin Goodwin
Jan 20, 2011·Human Vaccines·Paolo BonanniSara Boccalini
Apr 20, 2011·Pediatrics·James BaggsEric Weintraub
Apr 20, 2011·Pediatrics·Valerie Marshall, Norman W Baylor
May 25, 2011·Scandinavian Journal of Infectious Diseases·Tae Hyong KimMark Loeb
Jun 10, 2011·Health Affairs·Allison KennedySarah Landry
Jun 15, 2011·Lancet·Heidi J LarsonScott Ratzan
Jun 15, 2011·Lancet·E Richard MoxonGus Nossal
Jun 17, 2011·The Journal of Infectious Diseases·Mark Muscat
Jun 17, 2011·The New England Journal of Medicine·Manish M PatelUmesh D Parashar
Oct 14, 2011·Biologicals : Journal of the International Association of Biological Standardization·Noni E MacDonaldMary Appleton
Dec 17, 2011·The Pediatric Infectious Disease Journal·Jeanne LoughlinJohn D Seeger
Feb 10, 2012·JAMA : the Journal of the American Medical Association·Irene M ShuiEric Weintraub
Mar 1, 2012·Vaccine·Cornelia BetschMarybelle Stryk
Apr 17, 2012·Human Immunology·Gregory A Poland, Robert M Jacobson

❮ Previous
Next ❯

Citations

Sep 8, 2015·Vaccines·Alberta Di PasqualeNathalie Garçon
Feb 24, 2016·Human Vaccines & Immunotherapeutics·Jeremy K WardPierre Verger
Oct 24, 2018·Expert Review of Vaccines·Roy K PhilipPier Luigi Lopalco
Sep 15, 2016·The Pediatric Infectious Disease Journal·Roy K PhilipPierre Van Damme
Oct 2, 2020·American Journal of Public Health·Robin C VanderpoolWen-Ying Sylvia Chou
Nov 25, 2017·Indian Journal of Pediatrics·Jyoti JoshiNarendra Kumar Arora
Jan 25, 2020·American Journal of Law & Medicine·Dorit Rubinstein Reiss, Nili Karako-Eyal
Jul 1, 2021·Human Vaccines & Immunotherapeutics·Laura Chinenye IloguPierre Van Damme

❮ Previous
Next ❯

Software Mentioned

SHARE Anonymized

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Australian and New Zealand Journal of Public Health
F Baum
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Adel Mahmoud, Myron Levin
The Australian and New Zealand Journal of Psychiatry
R Larkins
© 2021 Meta ULC. All rights reserved